tiprankstipranks
Advertisement
Advertisement
Verastem price target raised to $18 from $16 at Alliance Global
PremiumThe FlyVerastem price target raised to $18 from $16 at Alliance Global
22d ago
Verastem: Strong Commercial Uptake and Expanding RAS/MAPK Oncology Pipeline Underpin Buy Rating and $18 Target
Premium
Ratings
Verastem: Strong Commercial Uptake and Expanding RAS/MAPK Oncology Pipeline Underpin Buy Rating and $18 Target
22d ago
Verastem Highlights AVMAPKI FAKZYNJA Strategy and Pipeline Risks
Premium
Company Announcements
Verastem Highlights AVMAPKI FAKZYNJA Strategy and Pipeline Risks
23d ago
Verastem price target raised to $18 from $15 at Mizuho
PremiumThe FlyVerastem price target raised to $18 from $15 at Mizuho
1M ago
3 ‘Strong Buy’ Stocks to Buy Now, According to Top Analysts
Premium
Market News
3 ‘Strong Buy’ Stocks to Buy Now, According to Top Analysts
2M ago
Verastem reports preliminary Q4 revenue $17.5M, consensus $16.53M
Premium
The Fly
Verastem reports preliminary Q4 revenue $17.5M, consensus $16.53M
2M ago
Verastem Shifts Focus to KRAS G12D and Pancreatic Programs
PremiumCompany AnnouncementsVerastem Shifts Focus to KRAS G12D and Pancreatic Programs
3M ago
Verastem ending RAMP 203 study doesn’t impact thesis, says Guggenheim
Premium
The Fly
Verastem ending RAMP 203 study doesn’t impact thesis, says Guggenheim
3M ago
Closing Bell Movers: Ekso Bionicis surges after Applied Digital deal
Premium
The Fly
Closing Bell Movers: Ekso Bionicis surges after Applied Digital deal
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100